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The Caenorhabditis elegans daf-2/insulin-like signaling pathway is critical for regulating development, longevity, metabolism and stress
resistance. We identified the 14-3-3 protein FTT-2 to be a new regulatory component of this pathway. We found that RNAi knock down of ftt-2
specifically enhanced the daf-2-mediated dauer formation phenotype. Furthermore, ftt-2 knock down caused the nuclear accumulation of DAF-16/
FOXO, the forkhead transcription factor that is the major downstream effecter of daf-2/insulin-like signaling, and enhanced the transcriptional
activities of DAF-16. In contrast to ftt-2, RNAi knock down of par-5/ftt-1, the only other gene predicted to encode a 14-3-3 protein in C. elegans,
did not show any notable effect on dauer formation, DAF-16 localization, or DAF-16 downstream gene transcription, underscoring the functional
specification of FTT-2 and PAR-5 despite their high sequence homology. Using co-immunoprecipitation, we revealed that FTT-2 formed a
complex with GFP-fused DAF-16 in C. elegans. Our results indicate that FTT-2 binds to DAF-16 in C. elegans and regulates DAF-16 by
sequestering it in the cytoplasm. A similar mechanism of regulation of FOXO by 14-3-3ζ has been reported in mammalian cells, highlighting the
high degree of conservation of the daf-2/insulin-like signaling pathway.
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Caenorhabditis elegans daf-16 encodes a forkhead transcrip-
tion factor (FOXO) that regulates many biological processes,
including dauer formation (Riddle and Albert, 1997), lifespan
(Lin et al., 1997; Ogg et al., 1997), reproduction (Gems et al.,
1998), and fat accumulation (Kimura et al., 1997). DAF-16 is
the major downstream effecter of the daf-2/insulin-like signal-
ing pathway. When the daf-2/insulin-like signaling pathway is
activated, the transmembrane receptor protein tyrosine kinase
DAF-2 triggers the activation of the downstream phosphatidy-
linositol 3-kinase AGE-1 and the protein kinase B/AKT, which
leads to phosphorylation of DAF-16 and retention of DAF-16 in
the cytoplasm (Brunet et al., 1999). When daf-2/insulin-like
signaling is reduced or inactivated, DAF-16 becomes depho-
sphorylated and migrates into the nucleus to affect gene
expression (Halaschek-Wiener et al., 2005; Lin et al., 2001;⁎ Corresponding author. Fax: +1 607 255 6249.
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doi:10.1016/j.ydbio.2006.10.013McElwee et al., 2003; Murphy et al., 2003). Interestingly,
reduced daf-2/insulin-like signaling in C. elegans results in
constitutive dauer formation (Kenyon et al., 1993; Kimura et al.,
1997; Riddle et al., 1981) and dramatic lifespan extension
(Kenyon et al., 1993) phenotypes that are completely dependent
on daf-16 (Gottlieb and Ruvkun, 1994; Larsen et al., 1995).
Therefore, nuclear translocation and eventual activation of
DAF-16 likely induces gene expression changes that promote
dauer formation and longevity extension (Halaschek-Wiener
et al., 2005; Lee et al., 2003a; McElwee et al., 2003; Murphy
et al., 2003).
The daf-2 pathway in C. elegans is entirely orthologous to
the insulin/IGF-1 signaling pathways in fruit flies and mammals
(Clancy et al., 2001; Holzenberger et al., 2003; Tatar et al.,
2001). Three mammalian DAF-16 orthologs (FOXO1, FOXO3
and FOXO4) have been characterized to regulate apoptosis,
oxidative stress response, DNA repair, and metabolism
(Birkenkamp and Coffer, 2003). In mammalian cultured cells,
the subcellular localization of FOXO3 is regulated by binding to
the 14-3-3ζ protein. When FOXO3 is phosphorylated by protein
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cytoplasm (Brunet et al., 1999). Since the insulin/IGF-1
signaling pathway is highly conserved, it is possible that C.
elegans DAF-16 is also regulated by a similar mechanism.
14-3-3 proteins are a family of highly conserved, abundant
cytoplasmic proteins identified in all eukaryotic organisms
examined. They are small (∼30 kDa), acidic proteins that
usually function as hetero or homo-dimers (Jones et al., 1995).
In general, 14-3-3 proteins bind to the phosphorylated form of
substrate proteins. A large number of proteins are found to
contain a consensus 14-3-3 recognition motif: RSXpSXP or
RXXXpSXP (Yaffe et al., 1997), in which the phosphorylated
serine is essential for binding (Pozuelo Rubio et al., 2004).
However, 14-3-3 proteins are also capable of binding to several
unphosphorylated ligands (Masters et al., 1999). By binding to
their substrates, 14-3-3 proteins can induce the conformational
change of the substrate proteins (Obsil et al., 2001; Yaffe,
2002), or sequester the substrate proteins in the cytoplasm
(Grozinger and Schreiber, 2000), or act as a scaffold that bridges
two interacting partners (Agarwal-Mawal et al., 2003). By
binding to a diverse group of signaling molecules, such as Raf-1
(Fu et al., 1994; Irie et al., 1994), Cdc25 phosphatase family
members (Chen et al., 2003; Forrest and Gabrielli, 2001; Peng
et al., 1997) and Bad (Datta et al., 2000), 14-3-3 proteins are
thought to participate in a wide variety of cellular processes,
including cell cycle checkpoints, DNA repair, cell differentia-
tion and apoptosis (Fu et al., 2000). 14-3-3 proteins typically
have several isoforms in one given organism. For example,
there are seven known isoforms in mammals (Ichimura et al.,
1988; Martin et al., 1993) and thirteen in Arabidopsis (DeLille
et al., 2001). In C. elegans, two 14-3-3 encoding genes have
been identified: par-5/ftt-1 and ftt-2 (Wang and Shakes, 1996).
par-5 is required for cellular asymmetry in the early C. elegans
embryo. PAR-5 regulates the asymmetric cortical localization of
PAR-1 and PAR-2 to the posterior and PAR-3, PAR-6 and PKC-
3 to the anterior (Morton et al., 2002). Until recently, the
function and protein substrates of FTT-2 were not known
(Berdichevsky et al., 2006; Wang et al., 2006).
Using gene-specific RNAi knock down, we show that the C.
elegans 14-3-3 protein FTT-2 regulates DAF-16 activities by
forming a protein complex with DAF-16 and preventing DAF-
16 from entering the nucleus to regulate transcription. Our
results indicate that the DAF-16 sub-cellular localization is
regulated by a conserved mechanism similar to that of FOXO in
mammalian cells. In contrast to ftt-2, par-5, the only other gene
predicted to encode a 14-3-3-like protein in C. elegans, has no
effect on dauer formation, DAF-16 localization or DAF-16
transcriptional activities, highlighting the functional specifica-
tion of two highly homologous 14-3-3 members.
Materials and methods
Strains and maintenance
The strains used in this paper were as follow: wild type N2 (from the
C. elegans Genetic Center), daf-16(mgDf47), rrf-3(pk1426), daf-2(e1370),
daf-16(mgDf47); xrls87[daf-16a∷gfp∷DAF-16B, rol-6(su1006)], daf-
2(e1370); daf-16(mgDf47); xrls87[daf-16a∷gfp∷DAF-16B, rol-6(su1006)],muIs84[pAD76(sod-3∷gfp)]. All strains were maintained on NGM plates
seeded with Escherichia coli OP50 as the food source.
Construction of ftt-2 and par-5 specific RNAi constructs
The sequences corresponding to the 3′ end and 3′UTR of the predicted ftt-2
and par-5 transcripts were amplified from genomic DNA of N2 worms by PCR.
The primers used for the par-5 RNAi construct: Forward primer: 5′-
tggacatctgacgttggagctga-3′; Reverse primer: 5′-ggaatgacaatagtgacggagtga-3′.
The primers used for the ftt-2 RNAi construct: Forward primer: 5′-acgctgc-
caccgatgacactg-3′; Reverse primer: 5′-aagggggaaaagccgtaacaaaa-3′. The ftt-2
primers and the par-5 forward primer are kind gifts from the Kemphues lab (K.
Kemphues, Cornell University, Ithaca NY). The RNAi constructs were generated
by inserting the ftt-2 or par-5 PCR products into the L4440 vector (a kind gift
from Dr. A. Fire, Stanford). The RNAi plasmids were transformed into E. coli
HT115 (Timmons et al., 2001) for feeding RNAi experiments. All other feeding
RNAi clones have been described previously (Lee et al., 2003b).
RNA interference
Feeding RNAi was performed as described (Lee et al., 2003b). Briefly,
RNAi bacteria were grown in Luria both with 50 μg ml−1 ampicillin at 37°C for
10–16 h, seeded onto NGM plates containing 2 mM IPTG, and induced at room
temperature overnight.
Dauer assay
Dauer assay for daf-2(e1370) strain was performed as described (Lee et al.,
2003b). daf-2(e1370) (Gems et al., 1998) worms at the L4 stage were put onto
RNAi plates and allowed to lay egg over night. The resulting self-progeny were
allowed to develop at 22°C. At ∼96 h after egg lay, the number of dauers and
adult worms on each plate were scored. Five plates were scored for each RNAi
treatment. Dauer assay for N2 or rrf-3(pk1426) strain was performed at 25°C
and the number of dauers in each population was scored at ∼72 h after egg lay.
The dauer assays were repeated three times.
DAF-16∷GFP localization assay
The construction and characterization of the daf-16(mgDf47); xrls87[daf-
16a∷gfp∷DAF-16B, rol-6(su1006)] transgenic strain have been described (Lee
et al., 2001). DAF-16∷GFP transgenic worms at the L4 stage were put onto the
RNAi bacteria and allowed to lay egg at 16°C over night. Self-progeny were
allowed to develop on the RNAi bacteria at 16°C till they were at the L3 stage.
The worms were cultured at 16°C to allow for a longer time for RNAi to take
effect before the worms reached the L3 stage for scoring. The GFP expression of
the DAF-16∷GFP worms feeding on the various RNAi bacteria was monitored
using a fluorescent microscope (Leica MZFL III) and images were captured
using a Hamamatsu ORCA-ER camera and OpenLab software.
Lifespan assay
Unless stated otherwise, lifespan assays were performed at 22°C. N2 or daf-
2(e1370) L4 larvae worms were allowed to lay egg over night on RNAi plates
and the progeny grew on RNAi plates at 16°C until the young adult stage. The
young adult worms were transferred onto RNAi plates containing 0.1 g/ml
FUDR to prevent the growth of progeny and shifted to 22°C. The adult
population was scored every day or every other day. Animals that failed to
respond to a gentle prodding with a platinum wire were scored as dead. Day 0 of
adult lifespan is the day that the adult worms were exposed to FUDR. Statistical
analysis was performed with the Kaplan–Meier method to test the null
hypothesis (SPSS v.11). The lifespan assays were repeated two times and similar
results were observed in both experiments.
Immunoprecipitation and Western Blot
N2, daf-16∷gfp, daf-2(e1370); daf-16∷gfp, or Psod-3∷gfp mixed staged
worms were collected by washing with M9 buffer, packed by centrifugation at
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worms were starved for 1 day to induce the GFP expression at a comparable
level before collected. daf-2(e1370); daf-16∷gfp worms were shifted to 25°C
for 6 h before collected to induce nuclear localization of DAF-16∷GFP.
Depending on the size of the frozen worm pellet, approximately 4× volume of
lysis buffer (50 mM HEPES pH 7.5, 1 mM EDTA, 150 mM NaCl, 10%
Glycerol, 0.1% Triton X-100, 1 mM sodium fluoride and protease inhibitor
cocktail) was added. The worm pellets were allowed to thaw at room
temperature completely and then frozen in liquid nitrogen again. The thaw-
and-freeze procedures were repeated four times. The worm lysate was then
sonicated using Markson Ultrasonic Processor for 10×15 s bursts with 30 s
pauses at the output of 60. The debris was removed by centrifugation. The worm
lysate was subsequently pre-cleared with 1/20 volume of protein A slurry
(Pierce) over night at 4°C. The pre-cleared lysate was incubated with antibody
(10 μl antibody per 400 μg total protein) for 1.5 h at 4°C. 1/10 volume of BSA-
blocked protein A slurry was then added and incubated for 1.5 h at 4°C. The
protein A beads were then washed with lysis buffer for six times and the bound
proteins were eluted by boiling in 2× sample buffer for 5 min. The anti-FTT-2
and anti-PAR-5 antibodies used for immunoprecipitation are kind gifts from Dr.
Andy Golden (NIDDK, National Institutes of Health, Bethesda, MD). The anti-
FTT-2 antibody was generated against a small peptide at the extreme C-terminus
of FTT-2 (CAATDDTDANETEGGN), and the anti-PAR-5 antibody has been
previously reported (Morton et al., 2002). Protein samples eluted from the
protein A beads were separated on a 10% SDS gel and transferred onto
nitrocellulose membrane (BA85 Protran® BioScience) followed by standard
Western blot procedure. The primary antibodies used: anti-ACTIN (mouse,
Chemicon International), anti-GFP (goat, Rockland), anti-FTT-2 (rabbit, a gift
from Dr. Andy Golden) and anti-PAR-5 (rabbit, a gift from Dr. Andy Golden).
The secondary antibodies are: anti-goat (Rockland), anti-mouse (Santa Cruz)
and anti-rabbit (Rockland). The immunoprecipitation experiments were
repeated three times.
Real-time PCR
Synchronized young adult worms of the indicated genotypes were grown at
16°C and collected by washing with M9 buffer and frozen in liquid nitrogen. Total
RNA of ∼100 μl worm pellet was isolated using the RNeasy® Mini Kit (Qiagen)
and quality control was done by both gel electrophoresis and UV absorbance
measurement. cDNAs were synthesized with random hexamers by using
SuperScript™ III First-Strand Kit (Invitrogen) according to the manufacturer's
protocol. Real-time PCR reactions were performed in a 20 μl volume using iQ™
SYBR®Green Supermix (BIO-RAD) in a 96-well plate. Duplicates for each sample
were included for one single reaction. The real-time PCR primers for act-1 are:
Forward primer: 5′-CCAGGAATTGCTGATCGTATGCAGAA-3′; Reverse pri-
mer: 5′-TGGAGAGGGAAGCGAGGATAGA-3′ (product length: 133 bp). Primers
for sod-3 are: Forward primer: 5′-TCGCACTGCTTCAAAGCTTGTTCAA-3′;
Reverse primer: 5′-CCAAATCTGCATAGTCAGATGGGAGAT-3′ (product
length: 98 bp). Primers for ftt-2: Forward primer: 5′-TCGACAAGTTCCT-
CATTCCA-3′; Reverse primer: 5′-TAGCTTTGCTGCGACTTCTC-3′ (product
length: 145 bp). Primers for par-5: Forward primer: 5′-AAGTCCCAGAAGGCT-
TACCA-3′; Reverse primer: 5′-TGGCTGCATCTTGTCCTTAG-3′ (product
length: 57 bp). Primers for C24B9.9: Forward primer: 5′-AAAAAGC-
CATGTTCCCGAAT-3′; Reverse primer5′-GCTGCGAAAAGCAAGAAAAT-3′
(product length: 137 bp). Primers for F53C3.12: Forward primer5′-CGTGTACA-
GAGACCCCGAAT-3′; Reverse primer: 5′-TGAAGTGCCACGTATTTGGA-3′
(product length: 92 bp). act-1was used as the internal control and the RNA level of a
gene of interest was normalized to the act-1 level for comparison. PCR reaction was
initiated at 95°C for 10 min for denaturation followed by a 40-cycles consisting of
15 s at 95°C and 60 s at 60°C. The real-time PCR experiments were repeated three to
four times using independent RNAi worms and RNA preparations. Dauer worms
grown at 22°C were not used for RT-PCR experiments because the asynchrony
among the different RNAi worms caused large variations in mRNA expression.
Brood size assay
The brood size of RNAi treated worms was determined at 22°C. For each
RNAi, ∼10 N2 L4 larvae worms were singled onto each RNAi plate and
allowed to lay egg over night and then transferred to fresh RNAi plate eachsubsequent days to lay egg until reproduction ended. The total number of eggs
laid and hatched on each plate was counted every day. The brood size assays
were repeated two times.
Developmental rate assay
The developmental rate of each RNAi worm population was determined at
22°C. For each RNAi, six gravid adults were allowed to lay egg for 1 h. The
times required for the progeny to reach adulthood were scored. The
developmental rate assays were repeated two times.Results and discussions
RNAi inactivation of ftt-2, but not par-5, enhances dauer
formation
To identify new components of the daf-2/insulin-like
signaling pathway, we used feeding RNAi to knock down a
select group of molecules annotated as being involved in signal
transduction (Rual et al., 2004) and specifically examined their
potential role in C. elegans dauer formation. In general, feeding
RNAi gene knock down is not an efficient way to reveal a
possible dauer phenotype, probably because feeding RNAi does
not work well in the nervous systems (Tavernarakis et al., 2000;
Timmons et al., 2001). Interestingly, at the semi-restrictive
temperature 22°C, the daf-2(e1370) mutant worms form 100%
dauer for ∼72 h and then exit dauer to develop into gravid/
sterile adults. This represents a sensitized genetic background
for using feeding RNAi to identify new players in daf-2-
mediated dauer regulation. We found that RNAi knock down of
the two 14-3-3 encoding genes, ftt-2 and par-5, greatly
enhanced the dauer arrest phenotype of daf-2(e1370). At
22°C, 100% of the daf-2(e1370) worms fed with ftt-2 RNAi
and 45% of the daf-2(e1370) worms fed with par-5 RNAi
remained as dauer at the 96 h time point, whereas only 4.5% of
the daf-2(e1370) worms fed with the empty vector control
L4440 RNAi remained as dauer at this time point.
ftt-2 and par-5 are the two putative 14-3-3 encoding genes in
C. elegans. The predicted transcripts of these two genes share
∼78.2% sequence identity at the nucleotide level and ∼85.9%
sequence identity at the amino acid level (Wang and Shakes,
1997). The ftt-2 and par-5 RNAi constructs we initially used
for the dauer screen include the full-length sequence of ftt-2 and
par-5 respectively. Stretches of consecutive identical sequence
as long as 19 base pairs (bp) are detected between the ftt-2 and
par-5 RNAi constructs and we suspected that these two RNAi
constructs might cross-react and caused the knock down of both
ftt-2 and par-5. In order to evaluate the specific roles of ftt-2
and par-5 in dauer formation, we generated gene-specific RNAi
constructs that targeted unique fragments corresponding to the
3′ coding and UTR regions of either ftt-2 or par-5 (Morton
et al., 2002). Sequence alignment indicates that the longest
stretch of sequence identity between the gene-specific ftt-2 and
par-5 RNAi constructs is only 6 bp. To verify the specificity of
the RNAi constructs, we used reverse-transcription real-time
PCR (RT-PCR) to quantify the ftt-2 and par-5 mRNA levels in
wild type (N2) and daf-2(e1370) animals that were undergoing
RNAi against either the ftt-2 or par-5 gene (Figs. 1A and B).
Fig. 1. The ftt-2 and par-5 RNAi constructs are gene-specific. N2 (A) or daf-2(e1370) (B) worms were exposed to feeding RNAi bacteria starting as L1 at 16°C. Total
RNAwas extracted from young adult RNAi worms for real-time-PCR analysis. The y-axis indicates the relative RNA levels normalized to the RNA expression levels
of the internal control act-1. The relative RNA levels for worms treated with the L4440 control RNAi is set as 1. The average of four independent experiments is shown
and the error bars represent standard error of the mean (S.E.M.). P-value of <0.01 (*) was determined by Student's t-test. FTT-2 or PAR-5 immunoblotting was
performed using young adult N2 worms exposed to the indicated RNAi bacteria at 16°C (C) or daf-2(e1370) dauer worms exposed to the indicated RNAi bacteria at
22°C (D).
85J. Li et al. / Developmental Biology 301 (2007) 82–91We detected a specific 2-fold knock down of the ftt-2 and par-5
mRNA levels in worms exposed to the corresponding gene-
specific RNAi. Furthermore, N2 worms fed with the par-5-
specific RNAi bacteria for two generations showed severe
embryonic lethality (data not shown), similar to that reported
previously (Morton et al., 2002). In contrast, N2 worms treated
with the ftt-2 specific RNAi for two generations exhibited
reduced brood size but did not show noticeable embryonic
lethality (Fig. 4). The molecular and phenotypic evidence
strongly supports that the ftt-2 and par-5 RNAi constructs we
generated specifically targeted the corresponding genes.
We also used anti-FTT-2 and anti-PAR-5 immunoblotting to
confirm that the FTT-2 and PAR-5 protein levels were reduced
in the daf-2(e1370) dauer worms treated with the gene-specific
RNAi at 22°C (Fig. 1D). We found that the anti-FTT-2 signal
was specifically reduced in daf-2(e1370) worms treated with
the ftt-2 RNAi, but not in worms treated with the par-5 RNAi.In contrast, we noticed that the anti-PAR-5 signal was reduced
in worms treated with either the par-5 or ftt-2 RNAi. Similar
results were also observed in N2 worms (Fig. 1C). Taken
together the immunoblotting, the RT-PCR, and the phenotypic
results, we propose that the anti-FTT-2 antibody specifically
recognizes FTT-2, whereas the anti-PAR-5 antibody may cross-
react with both PAR-5 and FTT-2.
We retested whether specific knock downs of either par-5 or
ftt-2 were able to enhance the dauer arrest phenotype of daf-2
(e1370) at 22°C. daf-2(e1370) worms were exposed to par-5 or
ftt-2 RNAi starting as embryos and allowed to develop at 22°C.
The empty vector L4440 was used as a negative control, and the
daf-2 RNAi was included as a positive control. At 96 h, when
most of the worms treated with L4440 RNAi exited dauer and
developed into sterile/gravid adults, the majority of the ftt-2
RNAi worms remained in the dauer stage (Table 1). In fact, the
ftt-2 RNAi treated daf-2(e1370) worms remained arrested as
Table 1
RNAi inactivation of ftt-2 promotes dauer formation in daf-2(e1370) at 22°C
Gene inactivation
by RNAi
L4440 daf-2 daf-16 ftt-2 par-5
daf-2 (e1370)
at 22°C
% of worms in
dauer stage
4.5% 100% 0% 99.5% 4.6%
Total number of
worms scored
334 214 423 184 328
N2 at 25°C % of worms in
dauer stage
0% 0.8% 0% 0% 0%
Total number of
worms scored
579 601 628 589 557
daf-2(e1370) mutant worms or N2 worms were exposed to the various RNAi
bacteria starting as embryos and allowed to develop at the indicated temperature.
Total number of worms scored and the percentage of worms remained in the
dauer stage on day 4 (for daf-2(e1370)) or day 3 (for N2) are shown. ftt-2 and
daf-2 RNAi dramatically enhances dauer formation in daf-2(e1370) at 22°C,
whereas par-5 RNAi behaves similarly to the L4440 control RNAi. However,
neither ftt-2 nor daf-2 RNAi was able to significantly enhance dauer formation
in N2 worms at 25°C.
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usually carried out for ∼240 h, similar to that of the positive
control daf-2 RNAi worms. In contrast, worms treated with
par-5 RNAi behaved similarly to worms treated with L4440
RNAi (Table 1). These results indicate that despite the high
sequence homology between par-5 and ftt-2, ftt-2 has theFig. 2. ftt-2 RNAi, but not par-5 RNAi, causes DAF-16∷GFP accumulation in the nu
as embryos at 16°C. DAF-16∷GFP expression of the RNAi worms at the L3 stage are
the 86 worms exposed to par-5 RNAi (panel C) showed DAF-16∷GFP nuclear local
out of 75 exposed to daf-2 RNAi (panel D) exhibited prominent DAF-16∷GFP nucle
exhibit cytoplasmic DAF-16∷GFP, probably due to variable RNAi efficiency. Theunique function of interacting with the daf-2 pathway and
affecting dauer formation.
RNAi knock down of ftt-2 in wild-type N2 or rrf-3(pk1426),
a strain that specifically enhances somatic RNAi effects
(Simmer et al., 2002), background resulted in normal develop-
ment and no observable dauer arrest phenotype at either 22°C or
25°C (Table 1 and data not shown). This is not surprising as
RNAi inactivation of daf-2 did not induce dauer formation in
the N2 background (Table 1). Moreover, our RT-PCR and
immunoblotting experiments indicate that the gene-specific ftt-
2 RNAi only causes a∼2-fold decrease in FTT-2 levels (Fig. 1).
It is possible that such a modest reduction in FTT-2, while
sufficient to promote dauer arrest in a sensitized background, is
not able to signal dauer arrest in a wild-type background.
Although a ftt-2 deletion mutant is available through the
knockout consortium (http://www.wormbase.org/), we are not
able to analyze its dauer formation phenotype because the
homozygous ftt-2 deletion mutant is not viable (JL and SSL,
unpublished data; Wang et al., 2006).
RNAi inactivation of ftt-2 promotes DAF-16∷GFP nuclear
localization
Our results indicate that reduced ftt-2 expression specifically
enhances the dauer formation phenotype associated withcleus. DAF-16∷GFP worms were exposed to the various RNAi bacteria starting
shown. None of the 78 worms exposed to the control L4440 RNAi (panel A) nor
ization. In contrast, 81 out of 88 worms exposed to ftt-2 RNAi (panel B) and 66
ar localization. A small number of daf-2 RNAi or ftt-2 RNAi worms continued to
images (A–D) were captured using identical magnification and exposure time.
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major downstream effecter of daf-2 signaling and increased
DAF-16 activity is critical for promoting dauer arrest, we
investigated whether RNAi knock down of ftt-2 might affect
daf-16 activity. A key step of DAF-16 regulation is the
translocation of DAF-16 from the cytoplasm to the nucleus.
We used feeding RNAi to inactivate ftt-2 in worms carrying an
integrated gfp-fused daf-16 transgene (daf-16∷gfp) (Lee et al.,
2001). The daf-16∷gfp worms fed with ftt-2 RNAi tended to
arrest at the L3 stage, but they developed to the L3 stage at a rate
similar to that of control RNAi worms. We therefore monitored
the DAF-16∷GFP localization in L3 animals. When the daf-
16∷gfp worms were fed with the control L4440 RNAi, the
DAF-16∷GFP fusion protein was evenly distributed in the
cytoplasm and nucleus of cells throughout the body of the
worm (Fig. 2A). Consistent with previous reports, when daf-2
was inactivated by RNAi, the DAF-16∷GFP fusion protein
became intensely localized in the nucleus of cells, althoughFig. 3. RNAi inactivation of ftt-2 results in the up-regulation of daf-16-dependent mR
16 (mgDf47) null mutant worms were exposed to the indicated RNAi starting as L1
PCR analysis. The y-axis indicates the RNA levels normalized to the RNA express
treated with the L4440 control RNAi is set as 1. The average of four independent esome cytoplasmic staining remained detectable (Fig. 2D) (Lin et
al., 2001). Interestingly, when ftt-2 was RNAi inactivated, the
DAF-16∷GFP fusion protein was also dramatically enriched in
the nucleus of cells (Fig. 2B), with a low level of cytoplasmic
DAF-16∷GFP remained detectable. In contrast, par-5 RNAi
knock down did not significantly affect the localization pattern
of DAF-16∷GFP (Fig. 2C). These results indicate that reduced
ftt-2 expression specifically induces the nuclear enrichment of
DAF-16.
Enhanced DAF-16 transcriptional activities upon ftt-2 RNA
Because nuclear translocation of DAF-16 may allow DAF-
16 to access its transcriptional targets, we next investigated
whether ftt-2 RNAi promoted the transcriptional activities of
DAF-16. To accomplish this, we exposed N2 or daf-16
(mgDf47) null mutant worms to ftt-2 RNAi and monitored the
mRNA levels of sod-3, a well-characterized DAF-16 directNA expression of sod-3 (A), C24B9.9 (B) and F53C3.12 (C). N2 worms or daf-
at 16°C. Total RNAwas extracted from young adult RNAi worms for real-time-
ion levels of the internal control act-1. The relative RNA levels for N2 worms
xperiments is shown and the error bars represent S.E.M.
Fig. 4. The brood size of ftt-2 RNAi worms upon one generation (A) or two
generations (B) of RNAi treatment. The average brood size of ∼10 worms for
each RNAi treatment is shown. Error bars represent S.E.M.
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Consistent with previous reports (Honda and Honda, 1999), we
detected ∼5-fold up-regulation of sod-3 levels in N2 worms
treated with daf-2 RNAi (Fig. 3A). Importantly, when N2
worms were fed ftt-2 RNAi, the expression levels of sod-3 were
upregulated about 2-fold (Fig. 3A), suggesting that the
transcriptional activities of DAF-16 were elevated. The
increased sod-3 expression in ftt-2 RNAi treated N2 worms
was not due to a change in daf-16 levels, as the daf-16 mRNA
levels were not significantly different in worms treated with the
different RNAi (data not shown). Consistent with the distinction
between ftt-2 and par-5 on dauer promotion and DAF-16∷GFP
translocation, reduction of par-5 did not affect DAF-16
transcriptional activities. Similar RNAi experiments performed
in the daf-16(mgDf47) null mutant indicate that the induction of
sod-3 expression observed in the ftt-2 or daf-2 RNAi worms
was mediated by daf-16. In daf-16(mgDf47) null mutant worms
treated with control L4440 RNAi, very low basal expression of
sod-3 was observed (Fig. 3A). Furthermore, in daf-16(mgDf47)
null mutant worms, neither ftt-2 nor daf-2 RNAi had any
significant effect on the low basal level of sod-3 expression
(Fig. 3A).
We examined the mRNA levels of additional DAF-16
downstream genes (Murphy et al., 2003). As expected, the
DAF-16 activated genes C24B9.9 and F53C3.12 exhibited
robust expression changes when worms were treated with daf-2
RNAi vs. daf-16 RNAi (Figs. 3B and C). For these two genes,
increased expression was also detected in ftt-2 RNAi worms,
consistent with an elevation of DAF-16 activities in ftt-2 knock
down worms. The results we described thus far suggest the
model that RNAi inactivation of ftt-2 induces the nuclear
translocation of DAF-16 and promotes the transcription of some
DAF-16 downstream genes.
RNAi inactivation of ftt-2 leads to shortened lifespan
Because reduced daf-2 signaling and increased daf-16
activities are often associated with enhanced dauer formation
and extended adult lifespan, we investigated whether RNAiTable 2
RNAi inactivation of ftt-2 shortens the lifespan of N2 worms but has no effect






N2 L4440 RNAi 15.200 15.000 36 N/A
ftt-2 RNAi 11.665 11.000 46 0.000 a
par-5 RNAi 16.440 19.000 39 0.380 a
daf-2 RNAi 39.925 40.000 40 0.000 a
daf-16 RNAi 10.216 10.000 38 0.000 a
daf-2(e1370) L4440 RNAi 48.604 50.000 53 N/A
ftt-2 RNAi 46.846 52.000 52 0.737 b
par-5 RNAi 50.533 52.000 60 0.764 b
daf-2 RNAi 45.644 50.000 45 0.980 b
daf-16 RNAi 12.705 11.000 42 0.000 b
The lifespan of N2 or daf-2(e1370) worms treated with the indicated RNAi was
determined at 22°C and the results of one representative experiment are shown.
a Compared to N2 worms fed with L4440 RNAi bacteria.
b Compared to daf-2(e1370) worms fed with L4440 RNAi bacteria.inactivation of ftt-2 in worms also affected adult lifespan. We
found that the ftt-2 RNAi knock down worms had a much
shorter adult lifespan compared to the control RNAi worms
(Table 2). In contrast, the par-5 RNAi knock down worms
exhibited normal lifespan (Table 2). Interestingly, ftt-2 RNAi
did not appear to affect the extended lifespan phenotype of
daf-2(e1370) worms (Table 2). Moreover, we determined
that the ftt-2 RNAi treated worms developed into adults at a
normal rate (control RNAi: 46.5±2.5 h, N=717; ftt-2 RNAi:
44.2±2.2 h, N=186) and exhibited no obvious developmental
defects. Taken together, the results indicate that ftt-2 RNAi
leads to a reduced lifespan in wild-type background, but ftt-2
RNAi does not appear to shorten lifespan by causing non-
specific sickness in worms (Berdichevsky et al., 2006; Wang et
al., 2006). The lifespan shortening effect of ftt-2 RNAi knock
down was somewhat unexpected based on our observation that
ftt-2 RNAi promoted dauer formation of daf-2(e1370) worms.
On the other hand, the lifespan and dauer phenotypes associated
with the daf-2/insulin-like signaling pathway have been shown
to be mediated by distinct effecter complexes. For instance, the
eak mutations robustly enhance the dauer formation phenotype
associated with the akt-1 mutant (the serine/threonine kinase
downstream of daf-2) but have little effect on the longevity of
the akt-1 mutant worms (Hu et al., 2006); the smk-1 gene
specifically interferes with the ability of daf-16 to affect
lifespan but has little effect on daf-16-mediated dauer regulation
(Wolff et al., 2006). Furthermore, because 14-3-3 proteins are
known to bind to a large number of substrates, FTT-2 is most
certainly involved in numerous diverse functions. RNAi
inactivation of ftt-2 will likely disrupt multiple biological
pathways that together may result in lifespan shortening. Two
recent papers implicated 14-3-3 proteins in mediating the
longevity promoting effect of SIR-2.1 by bridging the
interactions of SIR-2.1 and DAF-16 in the nucleus upon stress
signals (Berdichevsky et al., 2006; Wang et al., 2006). An
interesting possibility is that, in the ftt-2 knock down worms,
although more cytoplasmic DAF-16 are released into the
89J. Li et al. / Developmental Biology 301 (2007) 82–91nucleus to turn on some DAF-16 downstream genes, such a
beneficial effect may be countered by the dissociation of the
nuclear 14-3-3/SIR-2.1/DAF-16 protein complexes and result
in lifespan shortening (Table 2).
FTT-2 forms a complex with DAF-16 in vivo
14-3-3 proteins usually function by binding to phosphory-
lated ligands (Fu et al., 2000). Recent studies in cultured
mammalian cells indicate that the 14-3-3ζ isoform binds to
phosphorylated FOXO3a, one of the DAF-16 mammalian
homologs, and sequesters FOXO3a in the cytoplasm (Brunet et
al., 1999). Furthermore, in vitro pull-down assays show that the
mammalian 14-3-3ζ isoform is able to bind to phosphorylated
DAF-16 (Cahill et al., 2001). Therefore, it is possible that FTT-2
forms a complex with DAF-16 in C. elegans. We used co-
immunoprecipitation (co-IP) experiments to test this possibility.
Because we do not have an antibody that could detect
endogenous DAF-16 robustly, we used worm extracts from
the daf-16∷gfp strains and an anti-FTT-2 antibody for
immunoprecipitation. The co-IP experiments showed that
when FTT-2 was specifically immunoprecipitated, DAF-
16∷GFP was also recovered (Fig. 5A). In the same experiment,
a GFP protein driven by the sod-3 promoter (Psod-3∷gfp) was
not co-immunoprecipitated with FTT-2, indicating that FTT-2
and DAF-16∷GFP forms a specific complex in worms.Fig. 5. FTT-2 forms a complex with DAF-16∷GFP in C. elegans. (A) Worm e
16a∷gfp∷DAF-16B, rol-6(su1006)]) or daf-2(e1370); daf-16∷gfp worms that had b
anti-PAR-5 antibody and the precipitated proteins were immunoblotted with an anti-G
panel). Extracts from N2 and Psod-3∷gfp worms were used as negative controls. *: N
treated with ftt-2 RNAi or control L4440 RNAi and immunoprecipitated with an a
middle panel: immunoblotting with an anti-FTT-2 antibody; lower panel: immunoblo
input extracts.Furthermore, co-IP experiments carried out using worm extracts
from animals treated with ftt-2 RNAi showed that a much
reduced level of FTT-2 was immunoprecipitated and conse-
quently no detectable DAF-16∷GFP was co-immunoprecipi-
tated (Fig. 5B). We also carried out co-IP experiments using
daf-2(e1370); daf-16∷gfp worms that were cultured at the
non-permissive temperature for 6 h. Under this condition, the
majority of DAF-16∷GFP was observed in the nuclei of cells,
presumably due to the inactivation of DAF-2 at 25°C. We found
that reduced levels of DAF-16∷GFP was co-immunoprecipi-
tated with FTT-2 in daf-2(e1370); daf-16∷gfp worm extracts
compared to that of daf-16∷gfp, even though similar levels of
FTT-2 was immunoprecipitated in both extracts (Fig. 5A).
These results are consistent with the model that when daf-2/
insulin-like signaling is inactivated, DAF-16 becomes depho-
sphorylated and dissociates from 14-3-3 binding.
Our co-IP results together with the previously published in
vitro pull-down evidence (Cahill et al., 2001) suggest that FTT-
2 likely directly binds to phosphorylated DAF-16 in C. elegans.
Because 14-3-3 proteins are abundantly distributed in the
cytoplasm, the binding of FTT-2 with DAF-16 may sequester
DAF-16 in the cytoplasm. We hypothesize that when ftt-2 is
depleted by RNAi, DAF-16 is free to move into the nucleus and
execute its transcriptional role.
In our co-IP experiments, a low level of DAF-16∷GFP also
co-immunoprecipitated with PAR-5 when anti-PAR-5 wasxtracts from mixed staged daf-16∷gfp worms (daf-16(mgDf47); xrls87[daf-
een incubated at 25°C for 6 h were immunoprecipitated with an anti-FTT-2 or an
FP antibody (upper panel) and an anti-FTT-2 or an anti-PAR-5 antibody (lower
on-specific band. (B) Worm extracts were prepared from daf-16∷gfp L3 larvae
nti-FTT-2 antibody. Upper panel: immunoblotting with an anti-GFP antibody;
tting with an anti-actin antibody. Actin was included as a loading control for the
90 J. Li et al. / Developmental Biology 301 (2007) 82–91used for immunoprecipitation. The FTT-2 and PAR-5 anti-
bodies we used were generated against two distinct FTT-2 and
PAR-5 peptides (kind gifts from Dr. Golden). However, as
described earlier, in immunoblotting experiments, we found
that whereas the anti-FTT-2 antibody appears to be highly
specific, the anti-PAR-5 antibody may cross-react with the
FTT-2 protein (Fig. 1). Therefore, the weak binding we
detected between PAR-5 and DAF-16∷GFP may be due to
cross-reactivity of the anti-PAR-5 antibody to FTT-2. Alter-
natively, PAR-5 may indeed form a complex with DAF-
16∷GFP in worms. Because our experiments indicate that
PAR-5 does not affect daf-2-mediated dauer formation, DAF-
16 subcellular localization or DAF-16 transcriptional activities,
PAR-5 may be involved in other aspects of DAF-16 functions
(Berdichevsky et al., 2006).
Our analyses demonstrate that specific knock down of ftt-2,
but not par-5, affects dauer formation, DAF-16 localization,
and DAF-16 transcriptional activities. Such specificity is
consistent with the expression patterns of FTT-2 and PAR-5.
Using northern blotting analyses, par-5 is detected to express
highly in the embryos and its mRNA level drops drastically by
the L1 stage and remains low through larval development. ftt-2
is also found to be the most highly expressed in embryos but
its expression through larval stages only drops a little
compared to that in embryos (Wang and Shakes, 1997).
Also, whereas par-5 expression is highly germline enriched,
ftt-2 is not (Wang and Shakes, 1997). Using GFP fusion
strategies, PAR-5∷GFP is shown to express strongly in the
neurons and the intestine of transgenic larvae and FTT-2∷GFP
is shown to express most strongly in the pharynx and the
nervous system, and weakly in the intestine of transgenic
larvae (Wang et al., 2006). Based on the expression patterns of
FTT-2 and PAR-5, it is not surprising that FTT-2 has important
functions during C. elegans larval development. Furthermore,
as FTT-2 and PAR-5 express in overlapping but distinct
tissues, it is also expected that they will have different
functions. Interestingly, in our RT-PCR experiments (Fig. 1),
we noticed that specific knock down of par-5 led to ∼2-fold
increase in ftt-2 mRNA expression, probably due to a yet
unknown compensation mechanism. Our results indicate that
C. elegans has assigned different tasks for the closely related
members of the 14-3-3 family, further supporting the notion
that 14-3-3 proteins have isoform-specific functions (Roberts
and de Bruxelles, 2002).
In summary, we report here that the 14-3-3 protein FTT-2
specifically regulates dauer formation, DAF-16 subcellular
localization, and DAF-16 transcriptional activities in C.
elegans. We provide evidence that FTT-2 forms a complex
with DAF-16 in worm, similar to that in mammalian cultured
cells. The complex formation between FTT-2 and DAF-16
likely results in cytoplasmic sequestration of DAF-16 and
prevents it from regulating its transcriptional targets. Our results
advance the understanding of the regulation of DAF-16, an
important determinant of longevity, metabolism, and develop-
ment, and further highlight the high degree of conservation
between the C. elegans daf-2 and the mammalian insulin/IGF-1
signal transduction pathways.Acknowledgments
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